Bionano Genomics, Inc. (BNGO) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	8-K	10-Q	10-Q	10-K	10-Q	10-Q
Revenue:
Total revenue	8.7	7.4	8.2	6.7	5.7	6.3	4.7	3.9
Total revenue growth	29.9%	30.2%	30.4%	73.0%	79.8%	57.9%	112.0%	226.2%
Operating expenses:
Total cost of revenue	6.4	5.3	4.7	5.2	4.8	6.1	3.5	2.4

Operating expenses:
Research and development	14.6	13.9	14.0	11.8	10.5	9.2	6.5	4.1
Selling, general and administrative	26.9	26.0	25.3	21.8	20.3	19.8	15.3	13.8
Total operating expenses	89.4	85.2	45.7	72.3	66.4	64.1	47.2	38.2
Loss from operations	-39.2	-37.8	-37.5	-32.1	-29.9	-28.8	-20.7	-16.5
Operating margin	-453.0%	-510.4%	-456.8%	-480.9%	-525.7%	-456.7%	-444.2%	-427.3%

Other income (expense):
Interest income	0.7	0.7	0.7	0.2	0.1	0.0	0.0	-0.2
Interest expense	-0.1	-0.1	-0.1	-0.1	-0.1	-0.2		-0.3
Other income (expense)	-0.3	0.1	0.0	-0.2	0.0	0.0	-0.1	0.0
Total other income (expense)	0.4	0.7	0.0	-0.2	0.0	0.1	-0.1	-2.3
Loss before income taxes	-38.9	-37.1		-32.1	-29.9	-28.7	-20.7	-18.8
Benefit (provision) for income taxes	0.0	0.0	-1.8	0.0	0.0	5.8	0.0	0.0
Net loss	-38.9	-37.1	-38.7	-32.2	-30.0	-22.9	-20.8	-18.8

Net loss per share, basic (in dollars per share)	($1.24)	($0.12)		($1.13)	($0.11)	($0.08)	($0.07)	($0.07)
Net loss per share, diluted (in dollars per share)	($1.24)	($0.12)		($1.13)	($0.11)	($0.08)	($0.07)	($0.07)

Weighted-average common shares outstanding, basic (in shares)	31.5	302.0		28.6	284.6	276.8	280.2	278.9
Weighted-average common shares outstanding, diluted (in shares)	31.5	302.0		28.6	284.6	276.8	280.2	278.9